Skip to main content
Download PDF

Efficacy of ultrasonography and Tc-99m MIBI SPECT/CT in preoperative localization of parathyroid adenomas causing primary hyperthyroidism

BMC Medical Imaging volume 21, Article number: 87 (2021) Cite this article

Abstract

Background

Primary hyperparathyroidism (PHPT) results from an excess of parathyroid hormone (PTH) produced from an overactive parathyroid gland. The study aimed to explore the sonographic features of parathyroid adenomas and assess the diagnostic performance of ultrasonography (US) and Tc-99m MIBI SPECT/CT for preoperative localization of parathyroid adenomas.

Methods

A total of 107 patients were enrolled in this retrospective study who had PHPT and underwent parathyroidectomy. Of the 107 patients, 97 performed US and Tc-99m MIBI SPECT/CT examinations for preoperative localization of parathyroid nodules. The sensitivity and accuracy of each modality were calculated.

Results

In this study, residual parathyroid sign and polar vascular sign were identified as characteristic US features of parathyroid adenomas. These manifestations were closely related to the size of the abnormal parathyroid lesions. Among the 108 parathyroid nodules from 97 patients with PHPT, the sensitivity and accuracy of US for locating the parathyroid nodules were significantly higher than those of Tc-99m MIBI SPECT/CT (93.0% vs. 63.0% and 88.0% vs. 63.0% respectively; χ2 = 26.224, 18.227 respectively, P < 0.001). The differences between US + Tc-99m MIBI SPECT/CT and Tc-99m MIBI SPECT/CT-alone were statistically significant (χ2 = 33.410, 21.587 respectively, P < 0.001), yet there were no significant differences in the sensitivity or accuracy between US + Tc-99m MIBI SPECT/CT and US-alone (χ2 = 0.866, 0.187 respectively, P = 0.352 and 0.665).

Conclusions

US shows significantly better sensitivity and accuracy for localization of parathyroid adenomas than Tc-99m MIBI SPECT/CT. However, US combined with Tc-99m MIBI SPECT/CT is of great clinical value in the preoperative localization of parathyroid nodules in patients with PHPT.

Peer Review reports

Background

Primary hyperparathyroidism (PHPT) represents one of the most common endocrine disease, usually results from an excess of parathyroid hormone (PTH) produced from an overactive parathyroid gland. In the general population, the incidence of PHPT is approximately 0.1–0.7% [1]. The prevalence of PHPT is affected by age, sex, race, and gender, with postmenopausal women showing the highest prevalence worldwide. In recent years, its prevalence has increased further worldwide, which has been attributed, in part, to improved screening methodologies, usage of lithium and thiazide drugs, and increased rates of obesity and hypertension [2,3,4]. In Europe and the United States, PHPT is considered to be the third most common endocrine disease after diabetes and hyperthyroidism [5].

The diagnosis of PHPT is based upon elevated levels of both blood serum calcium and PTH, after excluding other causes of hyperparathyroidism or hypercalcemia. The classical manifestations of PHPT include musculoskeletal and renal disorders, such as kidney stones and nephrocalcinosis, along with cardiovascular, neuromuscular, and gastrointestinal symptoms. In patients with PHPT, adenomas are the most common and account for 73–89% of cases, while hyperplasia (11–21%) and parathyroid carcinomas (0.5–5.0%) are less common [6]. In terms of surgical approaches, recent studies have shown similar cure rates between minimally invasive parathyroidectomy and bilateral neck exploration [7, 8]. However, the success of minimally invasive surgery is highly dependent on the accurate preoperative detection and localization of abnormal parathyroid lesions.

The two most widely utilized screen modalities for the preoperative detection and localization of parathyroid adenomas are ultrasonography (US) and Tc-99m sestamibi (MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT). Exploring characteristics of US in patients with PHPT is of great significance for the accurate detection and localization of parathyroid adenomas.

Methods

Patient selection and study approval

In total, 107 patients consecutively diagnosed with PHPT in our institution between May 2018 and July 2020 were enrolled in this study. There were three exclusion criteria, including PHPT caused by post-operative incision implantation, secondary hyperparathyroidism, and tertiary hyperparathyroidism due to chronic renal disease. This study protocol was approved by the Institutional Review Board of Beijing Chaoyang Hospital, Capital Medical University. Due to the retrospective nature of this study, informed consent was waived by the committee.

US imaging

A senior radiologist (Dr. Lu Ruigang), with more than 16 years of experience, evaluated the US images. US was performed using a 5–14 Hz probe on the Canon Aplio 500 system (Canon Medical, Inc.). For scanning, the patient’s head was tilted to the side. The scanning area extended up to the mandible, down to the supraclavicular fossa, and on both sides to the lateral edge of the sternocleidomastoid muscle. The key scanning areas included the dorsal and inferior sides of the inferior pole of the thyroid, along with the dorsal side of the middle and upper part of the thyroid. The location, size, boundary, echo, calcification or cyst, and blood supply of the nodules were recorded.

SPECT/CT imaging

Following an intravenous injection of 555 MBq 99mTc-MIBI, early (10 min) and late (120 min) static images of 10 min of the neck and mediastinum were obtained using a dual-head combined SPECT/CT camera (Infinia Hawkeye 4, GE Healthcare, USA) with a low-energy high-resolution collimator in a 128 × 128 matrix. SPECT/CT was performed at the 120th minute immediately after the static images of the neck and mediastinum were obtained. SPECT data were acquired over 360°, yielding 60 projections at 15 s per projection in a 128 × 128 matrix with a 1.0 zoom. Computed tomography (CT) parameters were a tube current of 2.5 mAs, a voltage of 140 kVp, and 5 mm slice thickness.

A nuclear medicine specialist (Dr. Zhang Chun) with more than 20 years of experience assessed the Tc-99m MIBI SPECT/CT examinations, who was blinded to all clinical, radiological, and laboratory data. The 99mTc-MIBI SPECT/CT study was considered positive if focal activity retention was detectable on both early and late static images. Increased focal uptake areas were identified by SPECT, but not on planar images, and with a corresponding asymmetrical nodular lesions on CT were also interpreted as a positive scan. When the resected lesion found by US or Tc-99m MIBI SPECT/CT was confirmed as a parathyroidal abnormality pathologically, the lesion was defined as positive on US or Tc-99m MIBI SPECT/CT.

Statistical analysis

SPSS 23.0 software (IBM, Chicago, IL, USA) was used for statistical analysis. Measurement data were expressed as mean ± standard deviation and receiver operating characteristic (ROC) curves of working characteristics were drawn. Numerical data were expressed as percentages, and comparisons between groups were conducted by the Pearson’s chi-square tests. When the difference was statistically significant, row x column partition (subdividing RxC table) was used for pairwise comparison. P-values < 0.05 were considered statistically significant.

Results

There were 120 nodules in 107 patients (76 females and 31 males, aged 13–74) including 70 cases of single parathyroid adenoma, three cases of double adenoma (six nodules), one case of multiple endocrine neoplasia type 1 (MEN1) with four nodules, and one case of atypical parathyroid adenoma, twelve cases of ectopic parathyroid adenoma, one case of parathyroid lipoadenoma, four cases of parathyroid carcinoma, six cases of parathyroid hyperplasia with 13 nodules, three cases of parathyroid cysts, one case of a normal parathyroid gland, two cases of thyroid follicular adenoma, one case of papillary carcinoma, one case of nodular goiter, and one case of cervical lymph node (Table 1). The maximum diameter of the parathyroid nodules ranged from 0.35 to 5.80 cm (including nodules with maximum diameter ≧ 1.0 cm in 104 cases and < 1.0 cm in 16 cases).

Table 1 Patient demographics and baseline characteristics
Full size table

Parathyroid adenomas appeared as homogeneously hypoechoic nodules under US, with echogenic thyroid capsule separating them from the thyroid tissues, along with abundant blood flow. In addition, residual parathyroid signs and polar vascular signs are confirmed as characteristic sonographic features of parathyroid adenomas and these manifestations are closely related to the size of the parathyroid abnormal lesions (Figs. 1, 2). In total, 46 of the 107 parathyroid nodules (of the 120 nodules, there were six cases of non-parathyroid lesions and seven cases of false negative on US, which were excluded) had residual parathyroid signs. The AUC for predicting residual parathyroid signs by the maximum diameter of parathyroid nodules was 0.670, significantly different from that of 0.05 (P = 0.005). However, the accuracy of using the maximum diameter of parathyroid nodules to predict parathyroid sign was low (0.5 < Az ≤ 0.7), with a Youden’s index maximum of 0.269 and a cut-off value 1.55 cm. Hence, when the maximum diameter of the parathyroid nodule was less than 1.55 cm, the sensitivity and specificity of residual parathyroid sign in predicting parathyroid adenoma were 63.0% and 63.9%, respectively (Fig. 3). A total of 62 of the 107 parathyroid nodules showed signs of polar vascularity. The AUC for predicting polar vascular sign by the maximum diameter of parathyroid nodules was 0.675, significantly different from that of 0.05 (P = 0.001). However, the accuracy of using the maximum diameter of parathyroid nodules to predict polar vascular sign is low (0.5 < Az ≤ 0.7), with a Youden’s index maximum of 0.346 and a cut-off value of 1.35 cm. Hence, when the maximum diameter of the parathyroid nodules is more than 1.35 cm, the sensitivity and specificity of polar donor vessel sign in predicting parathyroid adenoma were 79.0% and 55.6%, respectively (Fig. 4). When the two signs were displayed at the same time, the joint sensitivity and specificity were 92.2% and 35.5%, respectively.

Fig. 1
figure 1

Parathyroid adenoma below the inferior pole of the right lobe of thyroid. The right inferior parathyroid adenoma clearly represents the residual parathyroid sign. Nodule and the thyroid gland move relatively with swallowing (a, b). Abundant blood flow signals on CDFI (c). The nodule was negative on planar images and Tc-99m MIBI SPECT/CT (d, e). The pathological results showed parathyroid adenoma (mainly chief cells and eosinophils), and fibrous capsule formation could be seen with the surrounding normal parathyroid gland (f)

Full size image
Fig. 2
figure 2

A complete type of intrathyroid parathyroid adenoma in the left lobe of thyroid. A homogeneously hypoechoic nodule in the left lobe of thyroid (a) that was negative in Tc-99m MIBI SPECT/CT, and the polar vascular sign (the supply vessel from the posterior branch of the superior thyroid artery) and anterior branch were detected by US (b, c). After clipping the superior thyroid artery intraoperatively, the blood supply in the nodule decreased significantly, which confirmed that the blood supply of the nodule came from the superior thyroid artery (d). After partial thyroidectomy and the nodule was resected, the US showed the parathyroid nodule was completely removed (e). The pathological results showed the parathyroid adenoma and surrounding thyroid tissue (f)

Full size image
Fig. 3
figure 3

Receiver-operating characteristics (ROC) curve analysis for the residual parathyroid sign. When the maximum diameter of the nodule was 1.55 cm, the sensitivity and specificity of the residual parathyroid sign in predicting parathyroid adenoma were 63.0% and 63.9%, respectively

Full size image
Fig. 4
figure 4

Receiver-operating characteristics (ROC) curve analysis for the polar vascularity sign. When the maximum diameter of the nodule was 1.35 cm, the sensitivity and specificity of the residual parathyroid sign in predicting parathyroid adenoma were 79.0% and 55.6%, respectively

Full size image

For the 108 parathyroid nodules in 97 patients with PHPT (of the 107 patients, 10 patients with 12 nodules were excluded for the reason that Tc-99m MIBI SPECT/CT was done in other hospitals or was not done before operation), the sensitivity and accuracy of US for locating the parathyroid nodules were significantly higher than those of Tc-99m MIBI SPECT/CT (93.0% vs. 63.0% and 88.0% vs. 63.0%,respectively; χ2 = 26.224, P < 0.001 for sensitivity; χ2 = 18.227, P < 0.001 for accuracy). The differences between US + Tc-99m MIBI SPECT/CT and Tc-99m MIBI SPECT/CT-alone were statistically significant (χ2 = 33.410, 21.587, respectively, P < 0.001), yet there were no significant differences of sensitivity (χ2 = 0.866, P = 0.352) and accuracy (χ2 = 0.187, P = 0.665) when compared US + Tc-99m MIBI SPECT/CT with US-alone. There were no statistically significant differences in specificity between the three methods (χ2 = 4.875, P = 0.087) (Table 2).

Table 2 Comparison of sensitivity, specificity, and accuracy in the detection of PHPT via three methods (%)
Full size table

A total of 93 in 100 (sensitivity = 93%) parathyroid lesions were detected by US, while 63 nodules were detected by Tc-99m MIBI SPECT/CT (sensitivity = 63.0%). Among the 108 lesions included in US, six cases were false positives (two cases were follicular adenoma, one case was PTMC, one case was nodule goiter, one case was a normal parathyroid gland, and one case was a cervical lymph node), while seven cases were false negative (two cases of the anterior mediastinum, two cases of the superior mediastinum, one case of the posterior pharynx wall, one case of the pericardium, and one case of the superior parathyroid gland). Three cases were false positives in Tc-99m MIBI SPECT/CT, and 37 of 108 lesions were false negatives in Tc-99m MIBI SPECT/CT but positive in US. In addition, ten malignant thyroid nodules were accidentally found in eight patients with thyroid papillary microcarcinomas during the parathyroid US, yet Tc-99m MIBI SPECT/CT could not help in these situations.

There was one patient with a recurrent adenoma after ablation and one patient with in situ recurrence after parathyroid carcinoma, with diameters of 1.3 cm and 0.8 cm, respectively. US could be used to accurately diagnose these patients, but Tc-99m MIBI SPECT/CT had not detected these two abnormal lesions. There were twelve cases of ectopic parathyroid nodules for which the detection rate of Tc-99m MIBI SPECT/CT was better than that of US (8/12 vs, 6/12, 66.6% vs. 50.0%), including six cases in the ectopic mediastinum, one case in the pericardium, and one case in the posterior pharyngeal wall. In addition, there were four cases of ectopic parathyroid adenoma (intrathyroid parathyroid adenomas) located in the thyroid parenchyma diagnosed by confirmed typical polar vascular sign, while Tc-99m MIBI SPECT/CT identified two in these four cases. Three cases of parathyroid cysts were found by US but not by Tc-99m MIBI SPECT/CT.

Discussion

Once the diagnosis of PHPT has been established, the detection and localization of the abnormal glands become top priority. Due to the characteristics of embryonic development, the position of the parathyroid gland varies, and the relationship between the parathyroid gland with the recurrent laryngeal nerve and inferior thyroid artery is complicated [9]. Parathyroid nodules often need to be differentiated from thyroid nodules, surrounding soft tissues, and posterior cervical lymph nodes. In this study, two cases of follicular tumors and one case of nodular goiter were mistaken for parathyroid lesions by US because they were located on the dorsal side of the thyroid gland and showed exogenous growth. A case of papillary carcinoma was misdiagnosed as an intrathyroidal parathyroid adenoma by US because of the appearance of polar vascular signs. Tc-99m MIBI SPECT/CT has been considered as the initial diagnostic choice, as it shows both cervical and mediastinal lesions, with high positive predictive value more than 80% [10, 11]. Although the reported sensitivity of Tc-99m MIBI SPECT/CT is high, it may not be sufficient for preoperative localization of parathyroid adenomas when used alone [12, 13].

In this study, the detection rate of abnormal parathyroid by US was significantly higher than 99mTc MIBI SPECT/CT (93.0% vs. 63.0%). In comparison, the sensitivity and accuracy of US in locating parathyroid nodules in 97 cases of PHPT were significantly higher than those of Tc-99m MIBI SPECT/CT (93.0% vs. 63.0% and 88.0% vs. 63.0%). However, a recent meta-analysis included 188 articles and 12 selected original articles with eligibility criteria showed that the pooled sensitivity of the two methods was not statistically different (83% vs. 80%). However, the pooled estimate of 99mTc MIBI SPECT/CT specificity was significantly higher than US [14]. These findings were not consistent with the results in the current study. However, the findings have been conflicting as many studies still demonstrate the superiority of US. There were 37 false negatives in Tc-99m MIBI SPECT/CT and the pathologies were parathyroid adenomas, hyperplasia, and parathyroid cysts, respectively. False negatives in Tc-99m MIBI SPECT/CT is mainly associated with smaller adenomas. In a recent study, Jones et al. [15] showed that Tc-99m MIBI SPECT/CT had a sensitivity of 93% for adenomas > 500 mg, yet the sensitivity was significantly reduced (51%) for adenomas < 500 mg. In this study, the maximum diameter of abnormal nodules less than 1 cm was detected in 16 cases, accounting for 16.7% of the total 120 nodules. The cellular composition of abnormal parathyroid nodules is also considered to be a factor affecting the accuracy of Tc-99m MIBI SPECT/CT. In research involving 122 cases of parathyroid adenoma, 26 of 68 adenomas (38%) constituted predominantly of chief cells were false negatives on Tc-99m MIBI SPECT/CT, while two (9.0%) of 23 adenomas formed predominantly by oxyphil cells and eight (25.8%) of 31 mixed adenomas were also false negatives on Tc-99m MIBI SPECT/CT [16]. These results suggest that the histological characteristics of parathyroid adenoma influence the imaging results of Tc-99m MIBI SPECT/CT. Although MIBI uptake is not related directly to PTH production and secretion, it is a marker of cell metabolism (mitochondrial uptake). Other factors may also affect the detection of abnormal parathyroid lesions, including serum calcium levels and the cystic degeneration of nodules. Another important confounding factor affecting the diagnostic value of Tc-99m MIBI SPECT/CT is concomitant thyroid nodules, which is known to be more frequent in PHPT patients than in general population. Particularly, some thyroid nodules exhibit intense MIBI uptake early with no tendency to wash-out or delayed wash-out, thereby mimicking parathyroid adenomas. In this study, three cases were false positives for Tc-99m MIBI SPECT/CT, of which the pathologies were nodular goiter, follicular adenoma, and normal parathyroid gland. Since Tc-99m MIBI SPECT/CT is a non-specific tumor imaging agent, it also accumulates in thyroid cancer and thyroid adenomas.

In this study, we also identified that residual parathyroid sign and polar vascular sign are characteristic US manifestations of parathyroid adenomas and this study proposes for the first time that the appearance of these two signs are closely related to the size of parathyroid tumors. The parathyroid gland is mainly composed of a large number of chief cells, along with some eosinophils and cell–matrix proteins. The chief cells are closely arranged, while the cytoplasm and matrix are rich in adipose cells. Hence, US demonstrates homogeneous hyperechoic parenchyma [17].Residual parathyroid signs are presented with a hyperechoic rim or cap around parathyroid hypoechoic tumors on US imaging, which has been confirmed by histopathologic results (Fig. 1). Only a few scholars have reported this manifestation of US previously [18].The sensitivity of this sign in the diagnosis of parathyroid nodules is 63.6%, and it is highly sensitive to parathyroid adenomas with a maximum diameter of ≤ 1.55 cm. However, it is difficult to find residual normal parathyroid glands when the tumor is large, which may be caused by smaller residual normal gland tissue and compression. Some pathologists have also proposed that the residual normal parathyroid tissue is a reliable standard for parathyroid adenoma, but it can only be seen in 50–60% of cases [19, 20]. This is similar to the results in this study, and the diagnosis of parathyroid adenoma cannot be ruled out when there is no residual normal parathyroid tissue. In this study, three cases of functional parathyroid cysts presented with residual parathyroid signs detected by US but not by Tc-99m MIBI SPECT/CT. Parathyroid cysts are rare and usually occur in the neck of the lower parathyroid gland with high levels of PTH. However, most scholars believe that parathyroid cysts represent degenerative adenomas [21, 22]. In fact, some of these cases in the current study presented with hyperparathyroidism. Approximately 95% of adenomas occur in the neck and usually obtain their blood supply from branches of the inferior thyroid artery. The normal parathyroid gland has no visible flow signal on color and power doppler due to thin nutrient vessels or slow velocity. Parathyroid adenomas are hypervascular and suspended by a vascular pedicle consisting of an extrathyroidal feeding artery enveloped in fat. The polar vascular sign is defined as the presence of an enlarged vascular pedicle around the nodule, which originates from the inferior or superior thyroid arteries (Fig. 2). The superior or inferior thyroid artery that terminates at the parathyroid adenoma is thicker than the contralateral artery at a similar position. In this study, the sensitivity of this sign in the diagnosis of parathyroid nodules is 79.0% for parathyroid adenomas with maximum diameter > 1.35 cm. To our current knowledge, some scholars have reported polar vascular sign but not associated it with the size of abnormal lesions detected by US. Previously, Lane et al. [23] used US to reveal extrathyroidal feeding arteries in the detection of abnormal parathyroid glands, but there were only few cases, no tracking of the whole source of the supply vessels, and no connection between this sign and the size of the parathyroid tumors mentioned. The weight of resected nodule was measured after operation in this literature, but the weight may include tumor and normal parathyroid. Thus, this method may be not objective enough and limits the accuracy of measurement. Meanwhile, some of the postoperative tissues may be broken and could not be weighed precisely. In another study [24], similar findings from 4D CT with polar vascularity were found. However, it is difficult to fully display the whole feeding vessel and their origin. Compared with traditional CT, the ionizing radiation of 4D CT is much higher, and the vascular reconstruction is time-consuming.

We found PTC in ten (10.3%) of the 97 PHPT cases, and 9 out of 10 cases (90%) were PTMC and did not involve any lymph node or distant metastases. The association between thyroid disease and PHPT was first described more than 70 years ago [25]. Several reports have described an increased incidence risk of cancer in patients with PHPT [26, 27]. Some scholars have found that PHPT is mainly accompanied by non-medullary carcinomas, especially PTC [28]. Previous studies have uncovered several susceptible factors of PTC in PHPT, such as the tumor-promoting effects of PTH, the goitrogenic effect, and increased mitotic activity induced by hypercalcemia and neck irradiation [29].

There were twelve cases of ectopic parathyroid nodules in this group. For which the display rate of Tc-99m MIBI SPECT/CT was better than that of US (66.6% vs. 50.0%). However, neither of the imaging modalities identified one case located in the posterior pharyngeal wall that was resected by intraoperative PTH monitoring. Tc-99m MIBI SPECT/CT is superior to US in the preoperative display of ectopic parathyroid nodules, especially those of ectopic locations like the retrotracheal region, retrosternal region, upper mediastinal, and intrathymic regions.

FNA is a feasible option for the suspicious nodules that cannot be identified by Tc-99m MIBI SPECT/CT or US. US-guided FNA of the suspected lesion with subsequent PTH measurement in the washout was first applied in the 1980s [30], with a sensitivity of 70–100% and specificity of 75–100% for parathyroid adenomas [31]. Other scholars believed that FNA has the risk of implantation metastasis along the biopsy tract, which is theoretically possible. However, the true incidence of this complication is controversial. In a study of 81 parathyroid samples, there were no cases of parathyroid tumor metastasis induced by FNA during a follow-up period of 5.8 years [32]. Another pitfall of parathyroid biopsy is atypical features, such as capsule infiltration, cellular pleomorphism, fibrous band, and increased proliferation index after the parathyroid biopsy. These histological changes are similar to atypical adenomas or parathyroid carcinomas and may also mislead pathologists [33].

Several limitations should be mentioned for this study. First, because this was a retrospective study, it may have some bias and sampling variation. Secondly, the diagnosis was made by experts in different departments, which may affect the statistical results. Lastly, a small number of negative cases resulted in a low specificity, which may lead to a certain deviation in the results.

Conclusion

US is highly sensitive, inexpensive, and non-radioactive. However, the accuracy of US is operator-dependent and needs a skillful eye to pick up abnormal parathyroid lesions. The residual parathyroid sign and polar vascular sign are characteristic US features of parathyroid adenomas causing primary hyperthyroidism and the appearance of these two signs is closely related to the size of nodules. US showed excellent diagnostic value for parathyroid adenomas, especially for those Tc-99m MIBI SPECT/CT-negative cases. However, Tc-99m MIBI SPECT/CT is superior to US in the detection of ectopic parathyroid adenomas. In this paper, the combination of US with Tc-99m MIBI SPECT/CT offered the best sensitivity and accuracy in the localization of abnormal glands. Hence, the combined imaging approach may improve surgical outcomes in patients with PHPT.

Availability of data and materials

Data and materials during the current study are available from the corresponding author upon reasonable request.

Abbreviations

US:

Ultrasonography

PHPT:

Primary hyperparathyroidism

PTH:

Parathyroid hormone

PTMC:

Papillary thyroid microcarcinoma

References

  1. Nieciecki M, Cacko M, Krolicki L. The role of ultrasound and nuclear medicine methods in the preoperative diagnostics of primary hyperparathyroidism. J Ultrason. 2015;15(63):398–409.

    Article  Google Scholar 

  2. Pal R, Mukherjee S, Bhadada SK, Bhansali A, Puravoor J, Behera A. Persistence of “non-dipping” pattern in blood pressure after curative parathyroidectomy in apparently normotensive patients with symptomatic primary hyperparathyroidism. Miner endocrinol. 2019;45:181–8.

    Google Scholar 

  3. Karras SN, Koufakis T, Tsekmekidou X, Antonopoulou V, Zebekakis P, Kotsa K. Increased parathyroid hormone is associated with higher fasting glucose in individuals with normocalcemic primary hyperparathyroidism and prediabetes: a pilot study. Diabetes Res Clin Pract. 2020;160:107985.

    Article  CAS  Google Scholar 

  4. Zivaljevic V, Jovanovic M, Diklic A, Zdravkovic V, Djordjevic M, Paunovic I. Differences in primary hyperparathyroidism characteristics between children and adolescents. J Pediatr Surg. 2019. https://doi.org/10.1016/j.jpedsurg.2019.09.023.

  5. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005;11(1):49–54.

  6. LiXiangzhou, XieXinli, angRuifang W, Yan L, Xiao F, Xingmin H. Comparative analysis of calcification features of primary and secondary hyperparathyroidism by Tc-99m MIBI SPECT/CT imaging. J Third Mil Med Univ. 2014;36(15):1626–9.

  7. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy. Arch Surg. 2005;140:472–9.

    Article  Google Scholar 

  8. Russell CF, Dolan SJ, Laird JD. Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br J Surg. 2006;93(4):418–21.

    Article  CAS  Google Scholar 

  9. Moller ML, Rejnmark L, Arveschoug AK, Hojsgaard A, Rolighed L. Clinical value of 11C-methionine positron emission tomography in persistent primary hyperparathyroidism—a case report with a mediastinal parathyroid adenoma. Int J Surg Case Rep. 2018;45:63–6.

    Article  CAS  Google Scholar 

  10. Lee VS, Wilkinson RH Jr, Leight GS Jr, Coogan AC, Coleman RE. Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging. Radiology. 1995;197(3):627–33.

    Article  CAS  Google Scholar 

  11. Perez-Monte JE, Brown ML, Shah AN, Ranger NT, Watson CG, Carty SE, Clarke MR. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology. 1996;201(1):85–91.

    Article  CAS  Google Scholar 

  12. Howson P, Kruijff S, Aniss A, Pennington T, Gill AJ, Dodds T, Delbridge LW, Sidhu SB, Sywak MS. Oxyphil cell parathyroid adenomas causing primary hyperparathyroidism: a clinico-pathological correlation. Endocr Pathol. 2015;26(3):250–4.

    Article  CAS  Google Scholar 

  13. Mehta S, Powle V, Chandrasekhar NH, Pillai V, Bushan V, Shetty V, Kuriakose AM, Sunil HV, et al. Localization of the parathyroid adenoma in mibi-negative cases: the value of a dedicated sonologist. Indian J Endocrinol Metab. 2018;22(6):860–3.

    Article  Google Scholar 

  14. Nafisi Moghadam R, Amlelshahbaz AP, Namiranian N, Sobhan-Ardekani M, Emami-Meybodi M, Dehghan A, Rahmanian M, Razavi-Ratki SK. Comparative diagnostic performance of ultrasonography and 99mTc-sestamibi scintigraphy for parathyroid adenoma in primary hyperparathyroidism; systematic review and meta- analysis. Asian Pac J Cancer Prev. 2017;18(12):3195–200.

    PubMed  Google Scholar 

  15. Jones JM, Russell CF, Ferguson WR, Laird JD. Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutive patients. Clin Radiol. 2001;56(7):556–9.

    Article  CAS  Google Scholar 

  16. Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP. Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg. 2006;30(5):697–704.

    Article  Google Scholar 

  17. Xingxin L, Lianfang D. Study on ultrasonographic features of normal parathyroids. J Clin Ultrasound Med. 2015;17(12):813–6.

    Google Scholar 

  18. Xia C, Zhu Q, Li Z, Hu M, Fang J, Zhong Q, Yue C, Bai Y. Study of the ultrasound appearance of the normal parathyroid using an intraoperative procedure. J Ultrasound Med. 2019;38(2):321–7.

    Article  Google Scholar 

  19. DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med. 2008;132(8):1251–62.

    Article  Google Scholar 

  20. Grimelius L, Johansson H. Pathology of parathyroid tumors. Semin Surg Oncol. 1997;13(2):142–54.

    Article  CAS  Google Scholar 

  21. Ippolito G, Palazzo FF, Sebag F, Sierra M, De Micco C, Henry JF. A single-institution 25-year review of true parathyroid cysts. Langenbecks Arch Surg. 2006;391(1):13–8.

    Article  Google Scholar 

  22. Ardito G, Fadda G, Danese D, Modugno P, Giordano A, Revelli L, Ardito F, Pontecorvi A. Coexistence of a parathyroid adenoma and parathyroid cyst causing primary hyperparathyroidism. J Endocrinol Invest. 2003;26(7):679–82.

    Article  CAS  Google Scholar 

  23. Lane MJ, Desser TS, Weigel RJ, Jeffrey RB Jr. Use of color and power Doppler sonography to identify feeding arteries associated with parathyroid adenomas. AJR. 1998;171(3):819–23.

    Article  CAS  Google Scholar 

  24. Bahl M, Muzaffar M, Vij G, Sosa JA, Choudhury KR, Hoang JK. Prevalence of the polar vessel sign in parathyroid adenomas on the arterial phase of 4D CT. AJNR. 2014;35(3):578–81.

    Article  CAS  Google Scholar 

  25. Kissin M, Bakst H. Co-existing myxedema and hyperparathyroidism; case report. J Clin Endocrinol Metab. 1947;7(2):152–8.

    Article  CAS  Google Scholar 

  26. Palmieri S, Roggero L, Cairoli E, Morelli V, Scillitani A, Chiodini I, Eller-Vainicher C. Occurrence of malignant neoplasia in patients with primary hyperparathyroidism. Eur J Intern Med. 2017;43:77–82.

    Article  Google Scholar 

  27. Pickard AL, Gridley G, Mellemkjæ L, Johansen C, Kofoed-Enevoldsen A, Cantor KP, Brinton LA. Hyperparathyroidism and subsequent cancer risk in Denmark. Cancer. 2002;95(8):1611–7.

    Article  Google Scholar 

  28. Lever EG, Refetoff S, Straus FH 2nd, Nguyen M, Kaplan EL. Coexisting thyroid and parathyroid disease—are they related? Surgery. 1983;94(6):893–900.

    CAS  PubMed  Google Scholar 

  29. Nilsson IL, Zedenius J, Yin L, Ekbom A. The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. Endocr Relat Cancer. 2007;14(1):135–40.

    Article  Google Scholar 

  30. Clark OH, Gooding GA, Ljung BM. Locating a parathyroid adenoma by ultrasonography and aspiration biopsy cytology. West J Med. 1981;135(2):154–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Kuzu F, Arpaci D, Cakmak GK, Emre AU, Elri T, Ilikhan SU, Bahadir B, Bayraktaoglu T. Focused parathyroidectomy without intra-operative parathormone monitoring: the value of PTH assay in preoperative ultrasound guided fine needle aspiration washout. Ann Med Surg (Lond). 2016;6:64–7.

    Article  Google Scholar 

  32. Kendrick ML, Charboneau JW, Curlee KJ, van Heerden JA, Farley DR. Risk of parathyromatosis after fine-needle aspiration. Am Surg. 2001;67(3):290–3 (discussion 293–294).

    CAS  PubMed  Google Scholar 

  33. Norman J, Politz D, Browarsky I. Diagnostic aspiration of parathyroid adenomas causes severe fibrosis complicating surgery and final histologic diagnosis. Thyroid. 2007;17(12):1251–5.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Baoqi Liu, Canon Ultrasound Sales Director at Shanghai Kangda Medical Equipment Group Corporation Ltd. for his strong support and assistance.

Funding

None.

Author information

Author notes

  1. Ruigang Lu and Wei Zhao contributed equally to this work as first authors

Authors and Affiliations

  1. Department of Ultrasound, Beijing Chaoyang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chao Yang District, Beijing, 100020, China

    Ruigang Lu, Wei Zhao, Li Yin & Ruijun Guo

  2. Department of Thyroid and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chao Yang District, Beijing, 100020, China

    Bojun Wei

  3. Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chao Yang District, Beijing, 100020, China

    Mulan Jin & Xiang Zhou

  4. Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China

    Chun Zhang

  5. Department of Echocardiography, Beijing Chaoyang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chao Yang District, Beijing, 100020, China

    Xiuzhang Lv

Authors
  1. Ruigang Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Li Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruijun Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bojun Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mulan Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiuzhang Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RL and WZ designed the study and wrote the manuscript. LY and XZ collected and analyzed the data. MJ advised on histological staining and analysis. BW and CZ contributed samples collection and intellectual input. XL and RG revised the manuscript critically for intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xiuzhang Lv.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Institutional Review Board and Ethics Committee of Beijing Chaoyang Hospital, Capital Medical University. According to the ethical committee policy, this is a completely anonymous, retrospective study and is exempt from informed consent from patients. We confirm that all methods were performed in accordance with the relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, R., Zhao, W., Yin, L. et al. Efficacy of ultrasonography and Tc-99m MIBI SPECT/CT in preoperative localization of parathyroid adenomas causing primary hyperthyroidism. BMC Med Imaging 21, 87 (2021). https://doi.org/10.1186/s12880-021-00616-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12880-021-00616-1

Keywords

BMC Medical Imaging

ISSN: 1471-2342

Contact us